Skip to main content
Log in

CT differentiation of poorly-differentiated gastric neuroendocrine tumours from well-differentiated neuroendocrine tumours and gastric adenocarcinomas

  • Gastrointestinal
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the differential CT features of gastric poorly-differentiated neuroendocrine tumours (PD-NETs) from well-differentiated NETs (WD-NETs) and gastric adenocarcinomas (ADCs) and to suggest differential features of hepatic metastases from gastric NETs and ADCs.

Materials and methods

Our study population was comprised of 36 patients with gastric NETs (18 WD-NETs, 18 PD-NETs) and 38 patients with gastric ADCs who served as our control group. Multiple CT features were assessed to identify significant differential CT findings of PD-NETs from WD-NETs and ADCs. In addition, CT features of hepatic metastases including the metastasis-to-liver ratio were analyzed to differentiate metastatic NETs from ADCs.

Results

The presence of metastatic lymph nodes was the sole differentiator of PD-NETs from WD-NETs (P = .001, odds ratio = 56.67), while the presence of intact overlying mucosa with mucosal tenting was the sole significant CT feature differentiating PD-NETs from ADCs (P = .047, odds ratio = 15.3) For hepatic metastases, metastases from NETs were more hyper-attenuated than those from ADCs.

Conclusion

The presence of metastatic LNs and intact overlying mucosa with mucosal tenting are useful CT discriminators of PD-NETs from WD-NETs and ADCs, respectively. In addition, a higher metastasis-to-liver ratio may help differentiate hepatic metastases of gastric NETs from those of gastric ADCs with high accuracy.

Key Points

• Presence of metastatic LNs is a useful differentiator of PD-NETs from WD-NETs.

• Intact overlying mucosa with mucosal tenting suggests PD-NETs more than gastric ADCs.

• Metastatic LNs are larger in size and greater in necrotic volume in PD-NETs.

• Hepatic metastases from gastric NETs are more hyper-attenuated than those from ADCs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

NETs:

Neuroendocrine tumours

WHO:

World Health Organization

WD-NETs:

Well-differentiated neuroendocrine tumours

PD-NETs:

Poorly-differentiated neuroendocrine tumours

ADCs:

Adenocarcinomas

LNs:

Lymph nodes

MDCT:

Multi-detector computed tomography

HU:

Hounsfield units

ROI:

Region of interest

ROC:

Receiver operating characteristic

AUC:

Area under the curve

References

  1. Bosman FT, Carneiro F, Hruban RH, Theise ND (eds) (2010) WHO classification of tumours of the digestive system. IARC France, Lyon

    Google Scholar 

  2. Rindi G, Kloppel G, Alhman H et al (2006) TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Archiv Int J Pathol 449:395–401

    Article  CAS  Google Scholar 

  3. Christopoulos E. (2007) Gastric neuroendocrine tumors: biology and management. Ann Gastroenterol. 18

  4. Scherübl H, Jensen RT, Cadiot G, Stölzel U, Klöppel G (2011) Management of early gastrointestinal neuroendocrine neoplasms. World J Gastrointest Endosc 3:133–139

    Article  PubMed Central  PubMed  Google Scholar 

  5. Crosby DA, Donohoe CL, Fitzgerald L et al (2012) Gastric neuroendocrinetumours. Dig Surg 29:331–348

    Article  PubMed  Google Scholar 

  6. Caplin M, Hodgson H, Dhillon A et al (1998) Multimodality treatment for gastric carcinoid tumor with liver metastases. Am J Gastroenterol 93:1945–1948

    Article  CAS  PubMed  Google Scholar 

  7. Tomassetti P, Migliori M, Caletti GC, Fusaroli P, Corinaldesi R, Gullo L (2000) Treatment of type II gastric carcinoid tumors with somatostatin analogues. N Engl J Med 343:551–554

    Article  CAS  PubMed  Google Scholar 

  8. Ahlman H, Friman S, Cahlin C et al (2004) Liver transplantation for treatment of metastatic neuroendocrine tumors. Ann N Y Acad Sci 1014:265–269

    Article  PubMed  Google Scholar 

  9. Ruszniewski P, Rougier P, Roche A et al (1993) Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. a prospective phase II study in 24 patients. Cancer 71:2624–2630

    Article  CAS  PubMed  Google Scholar 

  10. Wessels FJ, Schell SR (2001) Radiofrequency ablation treatment of refractory carcinoid hepatic metastases. J Surg Res 95:8–12

    Article  CAS  PubMed  Google Scholar 

  11. Kim SH, Lee JM, Han JK et al (2005) Effect of adjusted positioning on gastric distention and fluid distribution during CT gastrography. AJR Am J Roentgenol 185:1180–1184

    Article  PubMed  Google Scholar 

  12. Kim JI, Kim YH, Lee KH et al (2013) Type-specific diagnosis and evaluation of longitudinal tumor extent of borrmann type iv gastric cancer: CT versus gastroscopy. Korean J Radiol 14:597–606

    Article  PubMed Central  PubMed  Google Scholar 

  13. Rindi G, Bordi C, Rappel S, La Rosa S, Stolte M, Solcia E (1996) Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg 20:168–172

    Article  CAS  PubMed  Google Scholar 

  14. Neuroendocrine tumor. http://en.wikipedia.org/wiki/Neuroendocrine_tumor. Last modified on 8 May 2014, Visited on 1 June 2014

  15. Bordi C, D'Adda T, Azzoni C, Ferraro G (1998) Pathogenesis of ECL cell tumors in humans. Yale J Biol Med 71:273

    CAS  PubMed Central  PubMed  Google Scholar 

  16. Modlin IM, Tang LH (1996) The gastric enterochromaffin-like cell: an enigmatic cellular link. Gastroenterology 111:783–810

    Article  CAS  PubMed  Google Scholar 

  17. Ahn HS, Kim SH, Kodera Y, Yang H-K (2013) Gastric cancer staging with radiologic imaging modalities and UICC staging system. Dig Surg 30:142–149

    Article  PubMed  Google Scholar 

  18. Park HS, Lee JM, Kim SH et al (2010) Three-dimensional MDCT for preoperative local staging of gastric cancer using gas and water distention methods: a retrospective cohort study. Am J Roentgenol 195:1316–1323

    Article  Google Scholar 

  19. Japanese Gastric Cancer Association (1998) Japanese classification of gastric carcinoma – 2nd English edition. Gastric Cancer 1:10–24

    Article  PubMed  Google Scholar 

  20. Binstock AJ, Johnson CD, Stephens DH, Lloyd RV, Fletcher JG (2001) Carcinoid tumors of the stomach: a clinical and radiographic study. AJR Am J Roentgenol 176:947–951

    Article  CAS  PubMed  Google Scholar 

  21. Chang S, Choi D, Lee SJ et al (2007) Neuroendocrine neoplasms of the gastrointestinal tract: classification, pathologic basis, and imaging features1. Radiograp Rev Public Radiol Soc North Am Inc 27:1667–1679

    Google Scholar 

  22. Dromain C, de Baere T, Baudin E et al (2003) MR imaging of hepatic metastases caused by neuroendocrine tumors: comparing four techniques. Am J Roentgenol 180:121–128

    Article  Google Scholar 

  23. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277–300

    Article  PubMed  Google Scholar 

  24. Elias D, Lasser P, Ducreux M et al (2003) Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study. Surgery 133:375–382

    Article  PubMed  Google Scholar 

  25. Harring TR, Nguyen NTN, Goss JA, O'Mahony CA (2011) Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review. Int J Hepatol 2011:154541

    Article  PubMed Central  PubMed  Google Scholar 

  26. Vogl TJ, Naguib NN, Zangos S, Eichler K, Hedayati A, Nour-Eldin N-EA (2009) Liver metastases of neuroendocrine carcinomas: interventional treatment via transarterial embolization, chemoembolization and thermal ablation. Eur J Radiol 72:517–528

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Chris Woo, B.A. for his English editorial assistance in preparing the manuscript.

The scientific guarantor of this publication is Se Hyung Kim, Associate Professor, Department of Radiology, Seoul National University Hospital. The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article. This study has received funding by the Basic Science Research Program through the National Research Foundation of Korea [NRF] funded by the Ministry of Science, ICT & Future Planning [2013R1A1A3005937]. No complex statistical methods were necessary for this paper. Institutional Review Board approval was obtained. Written informed consent was waived by the Institutional Review Board. No study subjects or cohorts have been previously reported. Methodology: retrospective, observational, performed at one institution.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Se Hyung Kim.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, S.H., Kim, S.H., Kim, MA. et al. CT differentiation of poorly-differentiated gastric neuroendocrine tumours from well-differentiated neuroendocrine tumours and gastric adenocarcinomas. Eur Radiol 25, 1946–1957 (2015). https://doi.org/10.1007/s00330-015-3600-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-015-3600-z

Keywords

Navigation